PharmaSil

Antwerpen ·KBO/BCE: BE 1007.715.677

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	17.8%	20.4%	better than 46% of 1225 sector peers
Net result	€99k	€26k	better than 76% of 1224 sector peers
Equity	€108k	€142k	better than 45% of 1225 sector peers
Gross operating margin	€176k	€217k	better than 44% of 1223 sector peers
Total assets	€607k	€765k	better than 40% of 1225 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€607k
Fixed assets	21/28	€351k
Intangible fixed assets	21	€277k
Tangible fixed assets	22/27	€73k
Current assets	29/58	€256k
Stocks & contracts in progress	3	€78k
Amounts receivable within one year	40/41	€93k
Cash & bank	54/58	€82k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€607k
Equity	10/15	€108k
Contributions / capital	10/11	€10k
Reserves	13	€98k
Amounts payable	17/49	€499k
Amounts payable within one year	42/48	€498k
Trade debts payable within one year	44	€63k
Income statement
Gross operating margin	9900	€176k
Operating result	9901	€144k
Financial income	75	€2k
Financial charges	65	€204
Result before taxes	9903	€146k
Income taxes	67/77	€47k
Net result for the period	9904	€99k
Result to be appropriated	9905	€99k

Summary